Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAGEB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WISP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RXRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF382 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF148 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00551 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01088 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRICKLE2-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REV3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283454 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on